International Hepato-Pancreato-Biliary Association
IHPBA News
-
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 resin microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic...
Published
Read more -
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
Published
Read more -
SIR-Spheres® Y-90 Resin Microspheres Showed no Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds
Final Results of SIRveNIB Study presented at 2017 American Society of Clinical Oncology Meeting Chicago, IL, USA (5 June 2017) -- For the second time in less than two months, a major head-to-head...
Published
Read more -
Metastatic colorectal cancer patients treated first-line with SIR-Spheres® Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, REsect study shows
Surgeons’ blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated in the SIRFLOX study presented at 12th Annual...
Published
Read more -
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., March 14, 2017 (GLOBE NEWSWIRE) - - AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
Published
Read more
Corporate Partners
If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org
Find out more